Skip to main content
Livermore
Livermore
ZHEN

Fayez Sarofim & Co

SEC CIK
0000937729
Latest filing
Aug 14, 2026

The latest 13F from Fayez Sarofim & Co covers Q2 2026 (filed Aug 14, 2026): 300 long positions worth $42.5B. The top 10 holdings make up 48.8% of the portfolio, and the largest is Apple Inc. (AAPL) at 9.5%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
17
Est. +$45.8M
Added
72
Est. +$1.56B
Reduced
106
Est. −$1.29B
Sold out
11
Est. −$18.2M

Top 5 holdings

Share of this quarter's portfolio value

  1. AAPLApple Inc.
    9.5%$4.06BHistory
  2. MSFTMicrosoft Corp
    7.3%$3.08BHistory
  3. GOOGAlphabet Inc.
    6.5%$2.77BHistory
  4. NVDANVIDIA Corp
    4.7%$2.01BHistory
  5. AMZNAmazon Com Inc
    4.7%$1.99BHistory

Share of portfolio

Top 5 holdings and the other 295 positions, by share of portfolio value

  1. AAPL9.5%
  2. MSFT7.3%
  3. GOOG6.5%
  4. NVDA4.7%
  5. AMZN4.7%
  6. Other 295 positions67.3%

Biggest buys

New and added positions, by estimated amount bought

  1. AVGOBroadcom Inc.
    +$510.2MAddedHistory
  2. MSFTMicrosoft Corp
    +$213.3MAddedHistory
  3. CATCaterpillar Inc
    +$118.8MAddedHistory
  4. BXBlackstone Inc.
    +$101.5MAddedHistory
  5. BRK.ABerkshire Hathaway Inc
    +$94.4MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. AVGOBroadcom Inc.
    +1.21 pp0.1% → 1.3%History
  2. GOOGAlphabet Inc.
    +0.80 pp5.7% → 6.5%History
  3. AAPLApple Inc.
    +0.53 pp9.0% → 9.5%History
  4. AMZNAmazon Com Inc
    +0.37 pp4.3% → 4.7%History
  5. NVDANVIDIA Corp
    +0.34 pp4.4% → 4.7%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. TXNTexas Instruments Inc
    −$160.8MReducedHistory
  2. ASMLASML Holding NV
    −$155.4MReducedHistory
  3. ISRGIntuitive Surgical Inc
    −$108.9MReducedHistory
  4. INTUIntuit Inc.
    −$105.8MReducedHistory
  5. VRSKVerisk Analytics, Inc.
    −$98.7MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. XOMExxonMobil Holdings Corp
    −0.98 pp3.5% → 2.5%History
  2. INTUIntuit Inc.
    −0.77 pp1.2% → 0.4%History
  3. ISRGIntuitive Surgical Inc
    −0.55 pp1.4% → 0.9%History
  4. ABTAbbott Laboratories
    −0.43 pp1.1% → 0.7%History
  5. CMECME Group Inc.
    −0.29 pp0.9% → 0.6%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$42.5B
+$3.46B (+8.8%) vs. prior quarter
Positions
300
+6 vs. prior quarter
Top 10 concentration
48.8%
Top 10 as share of value
Turnover
3.2%
Q2 2026, one quarter
Average holding period
21.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $43.1B (Q3 2025)

Q1 2021: $27.2BQ2 2021: $29.8BQ3 2021: $30.2BQ4 2021: $33.4BQ1 2022: $31.6BQ2 2022: $27.4BQ3 2022: $25.3BQ4 2022: $27.1BQ1 2023: $28.6BQ2 2023: $28.6BQ3 2023: $29.6BQ4 2023: $32.7BQ1 2024: $33.6BQ2 2024: $37.1BQ3 2024: $39.3BQ4 2024: $41.1BQ1 2025: $40.2BQ2 2025: $41.7BQ3 2025: $43.1BQ4 2025: $41.7BQ1 2026: $39.1BQ2 2026: $42.5B
Q1 2021Q2 2026
13F filings of Fayez Sarofim & Co by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 2026300$42.5BAAPLMSFTGOOGvs. Q1 2026SEC
Q1 2026May 15, 2026294$39.1BAAPLMSFTGOOGvs. Q4 2025SEC
Q4 2025Feb 13, 2026297$41.7BAAPLMSFTGOOGvs. Q3 2025SEC
Q3 2025Nov 14, 2025305$43.1BMSFTAAPLGOOGvs. Q2 2025SEC
Q2 2025Aug 14, 2025308$41.7BMSFTAAPLPMvs. Q1 2025SEC
Q1 2025May 12, 2025311$40.2BAAPLMSFTAMZNvs. Q4 2024SEC
Q4 2024Feb 14, 2025312$41.1BAAPLMSFTAMZNvs. Q3 2024SEC
Q3 2024Nov 14, 2024285$39.3BAAPLMSFTAMZNvs. Q2 2024SEC
Q2 2024Aug 14, 2024278$37.1BAAPLMSFTNVOvs. Q1 2024SEC
Q1 2024May 14, 2024287$33.6BMSFTAAPLNVOvs. Q4 2023SEC
Q4 2023Feb 15, 2024289$32.7BAAPLMSFTNVOvs. Q3 2023SEC
Q3 2023Nov 15, 2023284$29.6BAAPLMSFTXOMvs. Q2 2023SEC
Q2 2023Aug 14, 2023278$28.6BAAPLMSFTPMvs. Q1 2023SEC
Q1 2023May 11, 2023281$28.6BAAPLMSFTPMvs. Q4 2022SEC
Q4 2022Feb 13, 2023281$27.1BAAPLMSFTPMvs. Q3 2022SEC
Q3 2022Nov 15, 2022278$25.3BAAPLMSFTKOvs. Q2 2022SEC
Q2 2022Aug 12, 2022289$27.4BAAPLMSFTPMvs. Q1 2022SEC
Q1 2022May 16, 2022320$31.6BAAPLMSFTTROWvs. Q4 2021SEC
Q4 2021Feb 11, 2022337$33.4BAAPLMSFTTROWvs. Q3 2021SEC
Q3 2021Nov 15, 2021310$30.2BAAPLMSFTTROWvs. Q2 2021SEC
Q2 2021Aug 13, 2021315$29.8BAAPLMSFTTROWvs. Q1 2021SEC
Q1 2021May 13, 2021289$27.2BAAPLMSFTTROW–SEC

13D and 13G filings

Companies where Fayez Sarofim & Co reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Fayez Sarofim & Co does not currently report owning 5% or more of any company.

Latest filings

4 filings on file made by Fayez Sarofim & Co or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Fayez Sarofim & Co
CompanyFiled (ET)FormStakeChangeEvent dateFiling
SBRSabine Royalty TrustFeb 28, 202413G/AOld format–––SEC
SBRSabine Royalty TrustApr 7, 202213G/AOld format–––SEC
SBRSabine Royalty TrustMar 3, 202213G/AOld format–––SEC
KMPBKEMPER CorpFeb 3, 202113G/AOld format–––SEC